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1. Introduction 
1.1 Importance of Spermatogonial Stem Cells (SSCs) 
Spermatogonial stem cells (SSCs) are undifferentiated germ cells that balance self-renewing 
and differentiating divisions to maintain spermatogenesis throughout adult life. This is a 
productive stem cell system that produces millions of spermatozoa each day while also 
maintaining rigorous quality control to safeguard germline integrity. SSCs are the only adult 
stem cells that are capable of self renewal and that differentiate to produce haploid cells 
transmitting genes to next generation. In the recent years, derivation of multipotent 
embryonic stem (ES)-like cells, which are capable of differentiating to three germinal layers, 
from SSCs in the testis, has been reported. This is of immense importance in medicine, basic 
science and animal reproduction and overcomes ethical issues pertaining to the use of 
human embryos for research. Since the population of SSCs in the testis is very low (< 1%), 
the identification of markers that are specifically expressed in SSCs aids in their efficient 
isolation. The characteristics of SSCs and ES-like cells in culture, and differential expression 
of genes in both these cell types can provide better understanding. In the present chapter, 
we would describe and compare the expression of SSC-specific markers in vivo and in vitro. 
We will also review the in vitro culture conditions of SSCs and characteristics of ES-like cells 
that differentiate from SSCs. This would enhance our perceptive of these special cells that 
has opened new avenues for stem cell researchers.  
1.2 Origin of Spermatogonial Stem Cell pool 
SSCs arise from gonocytes in the postnatal testis, which originally derive from primordial 
germ cells (PGCs) during foetal development. PGCs are a transient cell population that is 
first observed as a small cluster of alkaline phosphatase-positive cells in the epiblast stage 
embryo at about 7–7.25 days post psot coitum (dpc) in mice (Phillips et al., 2010). The 
specification of PGC is dependent on the expression of BMP4 and BMP8b from the 
extraembryonic ectoderm (Ginsburg et al., 1990; Lawson et al., 1999; Ying et al., 2001). 
During the formation of the allantois, the PGCs are passively swept away from the original 
position before they start migrating via the hindgut to arrive at the indifferent gonad 
(genital ridge) between 8.5 and 12.5 dpc in mice. PGCs replicate during the migratory phase 
and approximately 3000 PGCs colonize the genital ridges (Bendel-Stenzel et al., 1998). In the 
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male gonad at about 13.5 dpc, PGCs give rise to gonocytes, which become enclosed in 
testicular cords formed by Sertoli precursor cells and peritubular myoid cells. Gonocyte is a 
general term that can be subcategorized into mitotic (M)-prospermatogonia, T1-
prospermatogonia and T2-propsermatogonia (McCarrey 1993). M-prospermatogonia are 
located in the centre of the testicular cords, away from the basal membrane and continue 
proliferating until about 16.5 dpc of mouse development when they become T1-
prospermatogonia and enter the G0 stage of  mitotic arrest (McLaren 2003; Tohonen et al., 
2003). Gonocytes resume proliferation during the first week after birth (marking their 
transition to T2-prospermatogonia), concomitant with migration to the seminiferous tubules 
basement membrane (Clermont & Perey 1957). T2-prospermatogonia that colonize the 
basement membrane give rise to the first round of spermatogenesis as well as establish the 
initial pool of SSCs that maintains spermatogenesis throughout postpubertal life (Kluin & de 
Rooij 1981; McCarrey 1993; Yoshida et al., 2006). 
1.3 Dynamics of SSCs 
The kinetics of sperm production were first described in rodents (Oakberg 1956) with the 
knowledge of the presence of adult stem cells, such as hematopoietic stem cells (HSCs), 
researchers hypothesized that germ cell differentiation in the testis required a stem cell 
population. The presence of a stem cell population responsible for continual sperm 
production in the testis was demonstrated in 1994 (Brinster & Zimmermann). They 
documented the first successful spermatogonial stem cell (SSC) transplantation in mice 
resulting in donor-derived spermatogenesis. SSCs are part of a subset of male germ cells 
called undifferentiated spermatogonia (Caires et al., 2010). This subset includes Asingle (As) 
spermatogonia that are thought to be the SSCs and their progeny cells Apaired (Apr) and 
Aaligned (Aal) spermatogonia (figure 1). SSCs are a self-renewing population of adult stem 
cells capable of producing progeny for a continual production of sperm by sexually mature 
males. They help in maintaining a constant supply of undifferentiated spermatogonia, 
which are critical to the initiation of spermatogenesis and the long-term production of 
sperm. One must be careful to distinguish between spermatogonial stem cells (SSC) and 
spermatogonia in general. The term “spermatogonia” is used collectively to refer to a 
continuum of cells ranging from those resting on the basement membrane (known as either 
Aisolated or Asingle spermatogonia), to proliferating sub-populations (Apaired to Aaligned, 
spermatogonia) to differentiating sub-populations [A1-4, Intermediate and Type B 
spermatogonia]. The differentiating stages are committed to enter spermatogenesis, but 
whether the Aisolated cells represent the only spermatogonia with a true stem cell nature is 
not yet fully clear. The differentiation of germ cells from diploid undifferentiated 
spermatogonia to mature and haploid spermatozoa is supported by the Sertoli cells of the 
seminiferous epithelium. The formation of the SSC population is dependent on the 
associated niche in the microenvironment in the seminiferous tubules of the testis. This 
niche environment supplies factors and provides interactions crucial for the survival and 
development of SSCs. It is usually composed of adjacent differentiated cells, the stem cells 
themselves, and the extracellular matrix surrounding these cells. The somatic cells produce 
factors, which aid in the extrinsic regulation of the SSC self-renewal/differentiation process. 
SSCs represent a model for the investigation of adult stem cells because they can be 
maintained in culture, and the presence, proliferation and the loss of SSCs in a cell 
population can be determined with the use of a transplantation assay. 
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Fig. 1. Adult pig testis section stained with anti-UCHL-1 antibody. Spermatogonia are 
present as, Asingle (As), Apaired (Apr) and Aaligned (Aal) at the basement membrane of 
seminiferous tubule. The As spermatogonia are thought to be the spermatogonial stem cells 
(SSCs).  
2. Identification of SSCs 
2.1 Markers of SSCs 
Exploring markers for spermatogonia help to identify the stem cell pool in the testis. Certain 
rodent markers for germ cells and SSCs such as VASA, DAZL, PLZF, and GFR1are also of 
monkey (Hermann et al., 2007) and in other species. VASA expression marks spermatogonia 
in sheep (Borjigin et al., 2010), buffalo (Goel et al., 2010b) and bull (Fujihara et al., 2011) 
testis. It has been demonstrated that GFR1 is a marker for mouse SSCs and probably their 
progeny (Meng et al., 2000; Buageaw et al., 2005; Hofmann et al., 2005; Naughton et al., 2006; 
He et al., 2007), and that  KIT is a characteristic for the more differentiated spermatogonia, 
including type A1-4 spermatogonia (Yoshinaga et al., 1991). KIT expression is shown to mark 
pig gonocytes (Goel et al., 2007) and spermatogonia (Dirami et al., 1999). PLZF marks pig 
(Goel et al., 2007) and sheep (Borjigin et al., 2010) gonocytes and type-A spermatogonia. 
Because there is not a unique marker available to distinguish the SSCs and other 
undifferentiated spermatogonia, called Apr and Aal, it is helpful to use two or three 
antibodies to characterize their phenotypes. The GFR1 and POU5F1 antibodies stain the 
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same subset of mouse spermatogonia (He et al., 2007). POU5F1 also marks spermatogonia in 
buffalo (Goel et al., 2010b) and bull (Fujihara et al., 2011). GPR125 is also believed to be a 
marker for mouse spermatogonial stem/progenitor cells (Seandel et al., 2007). It is 
speculated that some of these markers as mentioned above will also be applicable to human 
spermatogonia. It has been recently shown that GPR125 may be a marker for human SSCs, 
as it is for mouse SSCs (He et al., 2010).  
A comparison of the markers for spermatogonia and their progenitors in human and 
rodents indicates that these spermatogonia share many but not all phenotypes. In rodents, 
ǂ6-integrin (CD49f), ǃ1-integrin (CD29), and Thy-1 (CD90) are surface markers for mouse 
spermatogonial stem/progenitor cells (Shinohara et al., 1999; Kubota et al., 2003). THY-1 
also marks bovine spermatogonia (Reding et al., 2010). CD9 is a surface marker for mouse 
and rat spermatogonial stem/progenitor cells (Kanatsu-Shinohara et al., 2004a). GFRǂ1 and 
RET are co-receptors for GDNF and markers for spermatogonial stem/progenitor cells 
(Buaas et al., 2004; Costoya et al., 2004; Buageaw et al., 2005; Hofmann et al., 2005; Naughton 
et al., 2006). In human, ǂ6-integrin is expressed in spermatogonia and their progenitors and 
was used to isolate and purify human spermatogonial cells by magnetic-activated cell 
separation (Conrad et al., 2008). Other rodent surface markers, such as CD90, GFRǂ1, and 
CD133, were also used to select human spermatogonia by magnetic-activated cell separation 
(MACS) and comparable results to ǂ6-integrin were obtained (Conrad et al., 2008). PLZF is 
characterized as a hallmark for mouse spermatogonial stem/progenitor cells (Buaas et al., 
2004; Costoya et al., 2004). In adult monkey, the expression of PLZF is confined to the Adark 
and/or Apale spermatogonia (Hermann et al., 2007). GPR125 has been demonstrated to be 
expressed in mouse spermatogonia and their progenitors (Seandel et al., 2007), and it is 
recently reported that GPR125 is also present in human spermatogonia (Dym et al., 2009). 
UCHL-1 is known to express in spermatogonia of mice (Kwon et al., 2004), monkey 
(Tokunaga et al., 1999) and humans (He et al., 2010). UCHL-1 protein expression is present 
specifically in the spermatogonia of domestic animal testes such as bull (Wrobel et al., 1995; 
Herrid et al., 2009), pig (Luo et al., 2006; Goel et al., 2007), sheep (Rodriguez-Sosa et al., 2006) 
and buffalo (Goel et al., 2010b). UCHL-1 protein expression is also specific to spermatogonia 
of wild bovids (Goel et al., 2010a). UCHL-1 also marks spermatogonia in the testis of Indian 
mouse deer (Moschiola indica) and slender loris (Loris tardigradus) (unpublished data). It is 
therefore likely that the expression of UCHL-1 is conserved in a variety of species. 
Collectively, the above studies suggest that some spermatogonial markers are conserved 
between rodents and humans and other species. In contrast, some other rodent markers for 
spermatogonia and their progenitors are not applicable to human and other species. This 
can be illustrated by the fact that ǂ1-integrin (CD29), a marker for rodent spermatogonial 
stem/progenitor cells, is not expressed in human spermatogonia but present in 
spermatocytes, spermatids, and spermatozoa in normal human testis (Schaller et al., 1993). 
Another example is that POU5F1 (Oct-4), a marker for mouse spermatogonial 
stem/progenitor cells (Ohbo et al., 2003; Ohmura et al., 2004; Hofmann et al., 2005), is not 
detected in adult human spermatogonia (Looijenga et al., 2003). POU5F1 shows a rather 
unique expression pattern in pig testis where spermatogonia show a weak staining, 
however, strong expression is present in differentiating germ cells such as spermatocytes 
and spermatids (Goel et al., 2008). Similarly, KIT is regarded as a marker for mouse 
differentiating spermatogonia (Yoshinaga et al., 1991; Schrans-Stassen et al., 1999; Dolci et 
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al., 2001), but it is undetected in human spermatogonia (Rajpert-De Meyts et al., 2003). 
Notably, some human markers for spermatogonia are also not applicable to rodents. As an 
example, the TSPY protein is preferentially expressed in elongated spermatids but not in 
spermatogonia of adult rat testis (Kido and Lau, 2006), unlike the expression pattern of the 
TSPY in adult human spermatogonia (Schnieders et al., 1996). Other rodent markers, 
including CD9 (Kanatsu- Shinohara et al., 2004b), CDH1 (Tokuda et al., 2007), neurogenin3 
(Yoshida et al., 2004, 2007), RET (Naughton et al., 2006), and STRA8 (Giuili et al., 2002), were 
demonstrated to be expressed in spermatogonia and their progenitors; however, whether 
these rodent markers are present in human spermatogonia remains to be clarified. Similarly, 
some human markers, such as CD133 (Conrad et al., 2008), CHEK2 (also known as chk2 
tumor suppressor protein) (Bartkova et al., 2001; Rajpert-De Meyts et al., 2003), and NSE 
(Neurone-specific enolase) (Rajpert-De Meyts et al., 2003), are also awaiting further studies 
to explore whether they are present in rodent spermatogonia and their progenitors. Such 
investigations would uncover further similarities and/or differences in spermatogonial 
phenotypes between human and rodents. 
2.2 Functional assay of SSCs 
Transplantation of isolated germ cells from a fertile donor male into the seminiferous 
tubules of infertile recipients can result in donor-derived sperm production. Therefore, 
this system represents a major development in the study of spermatogenesis and a 
unique functional assay to determine the developmental potential and relative 
abundance of spermatogonial stem cells in a given population of testis cells. The 
application of this method in farm animals has been the subject of an increasing number 
of studies, mostly because of its potential as an alternative strategy in producing 
transgenic livestock with higher efficiency and less time and capital requirement than 
the current methods such as microinjection of genes into fertilized eggs and somatic cell 
nuclear transfer.  
Germ cell transplantation (GCT), also referred to as spermatogonial stem cell (SSC) 
transplantation, is a powerful technology first introduced in 1994 by Brinster and colleagues. 
Although initially developed using a mouse model, GCT has important applications in the 
study and manipulation of spermatogenesis in many species. In this method, testis cells 
obtained from a fertile donor male are transferred into the seminiferous tubules of infertile 
recipient testes, where donor-derived sperm production can occur, allowing the recipient to 
sire progeny (Brinster & Avarbock, 1994; Brinster & Zimmermann, 1994). In essence, donor 
SSCs deposited in the lumen of the recipient seminiferous tubules are allowed by the Sertoli 
cells to migrate to the basolateral compartment of the tubule, to proliferate, form new 
colonies and initiate donor-derived spermatogenesis (Nagano et al., 1999; Ohta et al, 2000). 
Following the original introduction of GCT in mice (Brinster & Avarbock, 1994; Brinster & 
Zimmermann, 1994), the technique was also successful in rats (Jiang & Short, 1995;Ogawa et 
al., 1999b), monkey (Schlatt et al., 2000a) and goat (Honaramooz et al., 2003). In laboratory 
rodents, GCT not only provides a unique opportunity for gaining a new insight into 
spermatogenesis and the biology of the stem cell niche, but also presents a unique functional 
bioassay to test the competence of putative SSCs. Furthermore, GCT also offers a new 
strategy for preservation of male fertility and an alternative approach for generation of 
transgenic animals (Brinster 2002, 2007). 
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Fig. 2. Germ cell transplantation (GCT) in mice. (A) Germ cell depleted mice testes are 
extoriated through a ventral incision. (B) The testicular cell suspension is injected into 
seminiferous tubules through the efferent duct using a fine glass capillary.   
Rather surprisingly, cross-species (xenogeneic/heterologous) transplantation of testis cells 
from donor rats and hamster into recipient mice resulted in complete rat (Clouthier et al., 
1996) and hamster (Ogawa et al., 1999a) spermatogenesis. This development sparked an 
interest in the idea of using the laboratory mouse as a universal recipient model for testis 
cells from different donor species. However, GCT from genetically more distant donor 
species, including farm animals, into mice only resulted in colonization or proliferation of 
SSCs but not in complete spermatogenesis (Nagano et al., 2001, 2002; Dobrinski et al., 2000; 
Kim et al., 2006). We have recently shown that spermatogonia from endangered wild bovid 
(the Indian black buck; Antelope cervecapra L.) were able to colonize the recipient mice testis 
following GCT, however, showed no signs of proliferation or differentiation (Goel et al., 
2011). This block in differentiation of donor germ cells is believed to be due to the 
incompatibility of donor germ cells and mouse Sertoli cells (Shinohara et al., 2003). 
Although GCT from nonrodent species into the mouse testis did not result in complete 
spermatogenesis, it is still the only available bioassay for detecting the colonization potential 
of SSCs in a given population of donor testis cells from any species (Dobrinski et al., 1999a, 
b, 2000). Interestingly, when (rather than transferring isolated testis cells into the 
seminiferous tubules) small fragments of testis tissue were transplanted under the back skin 
of recipient mice, complete donor-derived spermatogenesis was observed from a wide range 
of donor species, including farm animal species (Honaramooz et al., 2002, 2004; Schlatt et al., 
2002b; Oatley et al., 2005; Rathi et al., 2006, 2008; Arregui et al., 2008; Ehmcke et al., 2008; 
Nakie et al., 2010).  
3. Pluripotential ability of germ stem cells in testis 
3.1 Introduction  
In the years 2006 and 2007, many articles were published, where somatic skin cells could be 
reprogrammed to ES-like cells, the so-called induced pluripotent stem (iPS) cells. Each 
report on the induction of pluripotency in mouse and human skin fibroblasts used retroviral 
delivery of key pluripotent stem cell genes such as, Oct-4 (Pou5f1), Sox2, c-Myc, and Klf4 
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(Takahashi and Yamanaka, 2006; Hanna et al., 2007; Meissner et al., 2007; Okita et al., 2007; 
Takahashi et al., 2007; Wernig et al., 2007). In the second step, transformed iPS cells were 
identified and selected by expression of pluripotent markers including Nanog (Okita et al., 
2007; Wernig et al., 2007) or Oct-4 (Wernig et al., 2007), or by ES-specific morphology 
(Meissner et al., 2007). These iPS cells had unique characteristics as they were germ-line 
competent and indistinguishable from ES cells derived from the embryo at the epigenetic 
level. Additionally, recent work has demonstrated that patient-autologous skin iPS cells can 
be genetically modified and used after differentiation by induction to cure a mouse model of 
sickle cell anemia (Hanna et al., 2007). Although this research paves the way toward stem 
cell therapy, it seems to be impractical for the iPS cells to be used in clinical application 
because of their instability and potential retroviral infections (Dym et al., 2009). 
As a result, it is essential and necessary to figure out more physiological methods to induce 
pluripotency from adult somatic cells or adult stem cells. More recent efforts have been 
taken to generate iPS cells from neural stem cells using only two transcription factors, Oct-4 
and either c-Myc or Klf4 (Kim et al., 2008). It has also been demonstrated that iPS cells can 
be produced from adult cells by non-integrating adenoviruses transiently expressing Oct-4, 
Sox2, Klf4, and c-Myc (Stadtfeld et al., 2008). However, it is still possible that these factors 
could somehow find their way into the genome of the iPS cells. Therefore, reprogramming 
of adult cells without the use of oncogenes would be very useful and safer as a means to 
produce ES-like cells. The proof of principle that spermatogonial stem cells/progenitor cells 
could be reprogrammed to pluripotent cells by biochemical means alone was first shown by 
Shinohara and colleagues (Kanatsu-Shinohara et al., 2004b). However, they could not derive 
ES-like cells from SSCs of adult mice. Guan et al. (2006) demonstrated that mouse adult 
spermatogonia, possibly the spermatogonial stem cells and/or their progeny, were able to 
reprogram biochemically to pluripotent ES-like cells. This was confirmed in mouse by 
(Seandel et al., 2007) showing that adult spermatogonia and/or their progenitors could 
indeed form pluripotent ES-like cells. Golestaneh and others (Conrad et al., 2008; Kossack et 
al., 2008; Golestaneh et al., 2009) have recently demonstrated a similar phenomenon in male 
germ cells and spermatogonia in the human testis. It is important to note that the 
SSCs/progenitor cells appear to reprogram spontaneously to pluripotency when  the cells 
are removed from their niche and when ES cell media is added. Thus, SSCs/progenitor cells 
have a great potential to be used as a safe means to generate ES-like cells that eventually can 
be used for clinical therapies of human diseases. Human ES cells are pluripotent stem cells 
that have the potential to differentiate into all the types of cell lineages and tissues in the 
body, and thus they are ideal cell sources for cell transplantation and gene therapy. 
However, the major concern is the ethical issues associated with obtaining human ES cells 
from IVF clinics. The human iPS cells have major advantages over human ES cells because 
there are no ethical issues involved and, more importantly, the iPS cells appear to be similar 
to ES cells in morphology, proliferation, and pluripotency, as evaluated by teratoma 
formation and chimera contribution. In contrast, the iPS cells have some disadvantages, e.g., 
safety is a major concern due to the potential of cell transformation or tumor formation 
because of the oncogenes from the transfected iPS. It may be possible to overcome these 
issues by generating pluripotent stem cells without oncogene transfer directly from 
spermatogonial stem cells by testicular biopsy. Thus, the generation of human ES-like cells 
from SSCs may offer a safer means of obtaining pluripotent stem cells than from the iPS 
cells. The identification of human SSCs is now especially important in view of the 
discrepancy between the Skutella report (Conrad et al., 2008) and the report by the Reijo-
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Pera group (Kossack et al., 2008). The Skutella group concluded that the ES-like cells derived 
from human spermatogonia (Spga) were in fact as pluripotent as true embryonic stem (ES) 
cells. The Reijo-Pera group noted that their cells differ from true ES cells in gene expression, 
methylation, and in their ability to form teratomas. Comparisons are difficult because the 
Skutella group used isolated Spga to get their ES-like cells, whereas the Reijo-Pera group 
used the entire testis biopsy without separating the Spga. It is possible that ES-like cells 
derived from isolated spermatogonial stem cells yield superior ES-like cells compared to 
using whole testis, but this remains to be determined. There are now three means to 
generate human pluripotent stem cells: (1) from a fertilized embryo as the traditional 
method; (2) from adult somatic cells through iPS technology; and (3) from adult SSCs 
and/or their progeny. One major advantage of the third approach is that the production of 
the ES-like cells is spontaneous, unlike method 2, where several genes, some cancer causing, 
is employed. Thus, human SSCs and/or their progeny have a great potential for cell- and 
tissue engineering-based medical regeneration for various human diseases. It is possible that 
in the near future men could be cured of their diseases using a biopsy from their own testes 
(Dym et al., 2009). 
3.2 Culture of SSCs and induction of ES-like colonies 
Kanatsu-Shinohara et al. (2004b) cultured SSCs in such a way that these cells propagated 
themselves, while retaining their capacity to repopulate a recipient mouse testis upon 
transplantation. A special medium, which was designed to culture hematopoietic stem cells, 
has been used for culture and contained several growth factors, including GDNF. In this 
culture system, a feeder layer is first formed that is composed of the contaminating somatic 
cells of the neonatal testis. Then, after 2 weeks and two passages, mitomycin-treated mouse 
embryonic fibroblasts (MEFs) are used as a feeder layer. During the first weeks of culture, 
the formed colonies consisted of SSCs, but, within 4-7 weeks, colonies that morphologically 
resembled ES cell colonies formed. Further work indicated that these colonies were indeed 
composed of multipotent ES-like cells. In order to maintain the multipotent character of 
these ES-like cells, they were subsequently cultured under a standard ES cell culture 
conditions in medium containing 15% fetal calf serum and LIF. Under these conditions, the 
cultured SSCs could not be propagated because of the lack of GDNF. ES-like colonies could 
only be obtained when the starting population of SSCs was derived from neonatal mice; 
when it was derived from older mice, ES-like colonies did not appear. However, cultures of 
SSCs derived from adult p53 (Trp53)-null mice did produce ES-like colonies. P53 is involved 
in the cellular response to DNA damage and a lack of P53 increases the chances of teratoma 
development. Possibly, P53-deficient SSCs are more capable of undergoing the transition 
into ES-like cells.  
An essentially similar protocol was followed by Seandel et al. (2007), except that this group 
used inactivated testicular stromal cells consisting of a mixture of CD34+ peritubular cells, ǂ 
-smooth-muscle-actin-positive peritubular cells and cells positive for the Sertoli cell marker 
vimentin, as a feeder layer because they had less success using MEFs. By this method, ES-
like colonies only appeared after more than 3 months in culture, more slowly than reported 
by Kanatsu-Shinohara et al. (2004b). A substantially different approach was taken by Guan 
et al. (2006). Their starting material was derived from 4- to 6-week-old mice and they did not 
use the stem cell medium described by Kanatsu-Shinohara et al. (2004b) but simply 
Dulbecco's Modified Eagle's Medium (DMEM) with serum and added GDNF, in which 
testicular cells were initially cultured for 4 to 7 days. These cells were then sorted for the 
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expression of STRA8 and subsequently cultured in DMEM under various conditions, but 
without adding GDNF. Colonies of ES-like cells formed when LIF was added to the medium 
and/or when the cells were cultured on a feeder layer of MEFs. The ES-like cells were 
further expanded by culture on MEFs and the addition of LIF.  
Hu et al. (2007) cultured germ cells of prepubertal mice under conditions that favour 
osteoblast differentiation and reported the emergence of cells that had characteristics of 
osteoblasts after several weeks in culture. In this system, there was no period of culture with 
added GDNF. Finally, Boulanger et al. (2007) employed no culture step at all. This group 
transplanted cells isolated from adult mouse seminiferous tubules, together with mammary 
cells, into mammary fat pads to obtain the differentiation of SSCs into mammary epithelial 
cells.  
We have shown that gonocytes from neonatal pig testis can attain multipotency during 
short-term culture (Goel et al., 2009). Freshly isolated gonocytes were found to have either 
weak or no expression of pluripotency determining transcription factors, such as POU5F1, 
SOX2 and C-MYC. Interestingly, the expression of these transcription factors, as well as 
other vital transcription factors, such as NANOG, KLF4 and DAZL, were markedly 
upregulated in cultured cells. The formation of teratomas with tissues originating from the 
three germinal layers following the subcutaneous injection of cells into nude mice from 
primary cultures confirmed their multipotency. 
Taken together, it does not seem that a very specific approach is required to obtain the 
transformation of SSCs into ES-like cells. This transformation can occur on different feeder 
layers and even without a feeder layer, if LIF is added to the culture medium. Furthermore, 
the culture medium also does not seem to play a decisive role in the transformation of SSCs 
into ES-like cells, as the groups of Kanatsu-Shinohara et al. (2004b) and Seandel et al. (2007) 
used a specific stem cell medium, whereas Guan et al. (Guan et al., 2006) used DMEM. All 
three groups added GDNF to the culture, either continuously (Kanatsu-Shinohara et al., 
2004b; Seandel et al., 2007) or only at the start (Guan et al., 2006). However, to obtain the 
transformation of SSCs into cells of another lineage, it might not be necessary for them to 
become ES-like cells first. Putting the SSCs in an osteoblast-inductive environment in culture 
(Hu et al., 2007) or transplanting them into a mammary gland-inductive environment in 
vivo (Boulanger et al., 2007) might be enough for these cells to change their lineage. This 
rather suggests that SSCs are restricted to the spermatogenic lineage owing to the 
seminiferous tubular environment in which they reside. Once outside of this environment, 
they can switch to another lineage depending on the particular niche in which they are 
placed.  
3.3 Gene expression in SSCs and ES-like cells 
A crucial question is what changes in gene expression accompany the transition from a 
cultured SSC to an ES-like cell? In this respect, it is interesting to study the possible changes 
in the expression of those genes that can transform a fibroblast into an ES-like cell, that is 
Myc, Oct4 (Pou5f1), Sox2 and Klf4 (Takahashi and Yamanaka, 2006; Wernig et al., 2007), in 
SSCs and in the ES-like cells derived from them. Kanatsu-Shinohara et al. (2008b) found that 
all four pluripotency genes are already expressed at low levels in cultured SSCs, although 
no NANOG (Kanatsu-Shinohara et al., 2004b) or SOX2 protein expression was found in 
these cells. In ES-like cells, the expression of these four genes is much increased. In addition 
to these pluripotency genes, the ES cell markers such as stage-specific embryonic antigen-1 
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(SSEA-1; FUT4) and, to a low level, Forssman antigen (GBGT1), were induced in the ES-like 
cells and, as in ES cells, high levels of alkaline phosphatase (AP) were also found (Kanatsu-
Shinohara et al., 2004b). Guan et al. (2006) assayed expression patterns in SSCs cultured 
under conditions that induced these cells to become ES-like cells. In this situation, it is 
difficult to categorize these cells as being either SSCs or ES-like cells as they might be in an 
in-between state. In these SSCs/early ES-like cells, Oct4, Nanog and SSEA1 were expressed 
(Guan et al., 2006). Indeed, the level of expression of Nanog and SSEA1 suggests that these 
cells were already on their way to becoming ES-like cells. Seandel et al. (2007) also studied 
gene expression levels before and after the transition of cultured SSCs to ES-like cells. Oct4 
was present in both cell types, but Nanog and Sox2 were strongly induced in ES-like cells, 
whereas the early spermatogonial markers Stra8, Plzf (Zbtb16), c-Ret and Dazl became 
inhibited. Besides these specific studies, Kanatsu-Shinohara et al. (2008b) also carried out a 
microarray study and found that a great many genes changed their expression levels during 
the transition from being a cultured SSC to an ES-like cell. Among these genes, over a 100 
were induced more than 5-fold in ES-like cells as compared with cultured SSCs, and another 
100 were inhibited more than 5-fold in ES-like cells. Clear differences between the patterns 
of genomic imprinting are also seen between cultured SSCs and ES-like cells. Kanatsu-
Shinohara et al. (2004b) studied the imprinting pattern of three paternally (H19, Meg3 and 
Rasgrf1) and two maternally (Igf2r and Peg10) imprinted regions in cultured SSCs and in the 
ES-like cells derived from them. Cultured SSCs show a completely androgenetic (paternal) 
imprinting pattern at the differentially methylated regions (DMRs) of these genes and loci; 
the DMRs of H19 and Meg3 are completely methylated and that of Igf2r is demethylated. By 
contrast, in the ES-like cells, the paternally imprinted regions are methylated to different 
degrees and the maternally imprinted regions (Igf2r and Peg10) are rarely methylated. 
Interestingly, the methylation patterns that are seen in the ES-like cells are not the same as 
those seen in proper ES cells, as the DMRs in ES cells are generally more methylated than 
those in ES-like cells, including the maternally imprinted regions. Furthermore, both 
Kanatsu-Shinohara et al. (2004b) and Seandel et al. (2007) reported that most of the ES-like 
cells obtained had a normal karyotype and that there was no evidence of clonal cytogenetic 
abnormalities. However, recently, Takahashi et al. (2007) did find some SSC-derived ES-like 
cells that were trisomic for chromosomes 8 or 11, which is a common chromosomal 
abnormality in ES cells. 
In conclusion, the transition from cultured SSCs to ES-like cells is accompanied by extensive 
changes in gene expression, during which three of the four pluripotency genes (the 
exception being Oct4, which is already expressed in mouse SSCs) become expressed at 
higher levels, along with many other genes. Furthermore, changes occur in the genomic 
imprinting patterns of these cells as they undergo this transition. Although the ES-like cells 
acquire the expression of ES cell-specific genes, the expression pattern of these genes in ES-
like cells is not identical to that seen in normal ES cells, with differences evident, for 
example, in the expression of brachyury, Gdf3, Forssman antigen, Nog and Stra8. 
4. Applications of SSCs 
4.1 Restoration of fertility 
SSC transplantation may have application for treating male infertility in some cases. For 
example, high-dose chemotherapy and total body radiation treatment of cancer can cause 
permanent infertility. While adult men can cryopreserve a semen sample prior to their 
www.intechopen.com
 
Pluripotent Stem Cells from Testis 
 
483 
oncologic treatment, this is not an option for pre-adolescent boys who are not yet making 
sperm. Using methods similar to those already established for other species, it may be 
possible for these young cancer patients to cryopreserve testis cells or tissue prior to cancer 
treatment and use those tissues to achieve fertility after they are cured (Orwig & Schlatt, 
2005; Goossens et al., 2008; Hermann et al., 2009). Recently, a non-human primate model of 
cancer survivorship to test the safety and feasibility of SSC transplantation in a species that 
is relevant to human physiology has been established (Hermann et al., 2007). Although SSC 
transplantation is not yet ready for the human fertility clinic, it may be reasonable for young 
cancer patients, with no other options to preserve their fertility, to cryopreserve testicular 
cells (Schlatt et al., 2009). Ginsberg and co-workers have been cryopreserving testicular 
tissue for young cancer patients since 2008 and report that this intervention is acceptable to 
parents and that testicular biopsies caused no acute adverse effects (Ginsberg et al., 2010). A 
human SSC culture system would be particularly useful in this setting because a few SSCs 
could be obtained in a small biopsy and expanded to a number sufficient for transplantion 
therapy. 
4.2 Genetic modification 
4.2.1 Genetic modification of rodents  
The establishment of SSCs led to the development of a new strategy for generating a 
genetically modified animal as an alternative or a potentially superior method to the 
conventional ES-based technology. First, SSCs are infected or transfected with a viral or 
plasmid vector carrying a drug-resistant gene. Individual clones of drug-resistant SSCs cells 
are selected and expanded in vitro. After DNA analysis, genetically modified SSCs are 
transplanted to infertile mice. In theory, half of spermatozoa that developed from the SSCs 
carry the transgene. Finally, recipient male mice are crossed with female mice to yield 
heterozygous transgenic mice with a theoretical success rate of 50%. In the conventional ES 
cell-based technology, the frequency of heterozygous transgenic mice depends on the 
properties of chimera mice. In some cases, no germline chimera can be found in the chimera 
population. In this respect, SSCs which are committed to spermatogenesis are 
advantageous. When SSCs were transfected with a plasmid vector bearing a drugresistant 
gene and used for the production of transgenic mice based on this method, approximately 
50% of offspring derived from a drug-resistant clone maintained a transgene (Kanatsu-
Shinohara et al., 2005). Mice lacking a specific gene (i.e. occludin) by homologous DNA 
recombination was then successfully produced (Kanatsu-Shinohara et al., 2006). 
Homozygous mutant mice showed signs of chronic gastritis, osteoporosis and a loss of 
acidic granule in the salivary glands, similar to the occludin knockout mice generated using 
ES cells (Saitou et al., 2000). From these finding, it was demonstrated that SSCs can be used 
for gene targeting in a similar manner to ES cells. 
4.2.2 Application to generation of knockout animals in domestic species 
The method for generating genetically modified mice based on ES cell technology has 
become a conventional experimental technique, and contributed to the functional analyses 
of many genes. Under current culture conditions, SSCs grow slower than ES cells. For 
example, clonal expansion from a single transfected SSCs requires mixing with non-
transfected SSCs to maintain cell densities during drug selection. Thus, SSC-based 
transgenic technology is not yet useful as ES cell-based technology. However, SSC-based 
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technology is potentially applicable to animal species other than mouse, and this is the 
greatest advantage of this technology. At present, ES cell-based transgenesis is feasible only 
in mice, and cloning by somatic cell nuclear transfer is extremely difficult or impossible due 
to the low proliferation potential of somatic cells and the poor success rates of nuclear 
transfer. If SSC culture conditions specific for animal species are established, animal 
transgenesis may become feasible in other species. Specifically, SSCs are derived from the 
testes of rat, hamster and cattle (Hamra et al., 2005; Ryu et al., 2005; Aponte et al., 2008; 
Kanatsu- Shinohara et al., 2008c). Hamsters have been historically difficult to manipulate 
genetically; however, the SSC technology may provide a good animal model. Bovine SSCs 
may be useful for the cattle industry as an important application. In particular, rats are 
important experimental animals that are larger than mice and have been used in various 
research areas. Therefore, SSC technology will be highly beneficial if it allows unlimited 
transgenesis in rats. Transplantation of SSCs is an essential step in SSC-based animal 
transgenesis and is technically challenging. The efficiency of this method is low in large 
animals (Ogawa et al., 1999b). Development of technologies for xenogeneic transplantation 
and in vivo spermatogenesis, in addition to the determination of culture conditions, are 
anticipated for universal application to various species in the future. With regard to 
xenogeneic transplantation from rats to mice, normal rat offspring were successfully born 
after transferring rat spermatids and spermatozoa developed in the mouse testes into rat 
oocytes by in vitro microinsemination (Shinohara et al., 2006; Kanatsu-Shinohara et al., 
2008a). 
4.3 Regenerative therapy 
Recent advances in cellular therapies have led to the emergence of a multidisciplinary 
scientific approach to developing therapeutics for a wide variety of diseases and genetic 
disorders. Although most cell-based therapies currently consist of heterogeneous cell 
populations, it is anticipated that the standard of care needs well-characterized stem cell 
lines that can be modified to meet the individual needs of the patient. Extensive research in 
the area of regenerative medicine is focused on the development of cells, tissues and organs 
for the purpose of restoring function through transplantation. The general belief is that 
replacement, repair and restoration of function is best accomplished by cells, tissues or 
organs that can provide the appropriate physiological/metabolic functions more efficiently 
than any mechanical devices, recombinant proteins or chemical compounds. Several cell-
based strategies are currently being investigated, including cell preparations from 
autologous parenchyma or established cell lines, as well as cell therapies derived from a 
variety of stem cell sources such as bone marrow or cord blood stem cells, embryonic stem 
cells, as well as cells, tissues and organs from genetically modified animals. Several lines of 
evidence have suggested extensive proliferation activity and pluripotency of germline stem 
cells, including SSCs. These characteristics provide new and unprecedented opportunities 
for the therapeutic use of SSCs for regenerative medicine. 
Guan et al. (2006) succeeded in developing a procedure for the isolation and purification of 
SSCs from adult mouse testis. They were able to isolate and culture these cells in culture 
medium containing the precise combination of cellular growth factors needed for the cells to 
reproduce themselves in vitro. These cells were characterized with regard to their molecular 
profiles and these were compared via molecular profiling of embryonic stem cells using a 
stem cell array which contains relevant genes related to stem cell metabolism. The results 
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indicate that SSCs share many molecular characteristics with embryonic stem cells. On the 
cellular level, SSCs resemble embryonic stem cells; they form an embryoid body structure 
after 2 weeks of culture. Stem cell potential of isolated SSCs was examined using the 
transplantation technique. This method allowed SSCs to recolonize the seminiferous tubules 
of germ cell-depleted mice and regenerate spermatogenesis. These cells are able to 
differentiate into various cell types of three germ layers in vitro (Guan et al., 2006, 2007). In 
contrast to ESCs, the use of SSCs for cell transplantation will allow establishment of 
individual cell-based therapy, because the donor and recipient are identical. In addition, any 
ethical problems are avoided.This approach provides an accessible in vitro model system for 
studies of mammalian gametogenesis, as well as for developing new strategies for 
reproductive engineering, infertility treatment and establishment of regenerative therapy.  
4.4 Conservation biology  
Thus far, most works on technologies of assisted reproduction in males have focused on 
mature spermatozoa. Successful semen collection, cryopreservation, and thawing techniques 
have been determined for a number of species. Advancements in the handling and storage 
of mature sperm have revolutionized the practice of both human and veterinary clinical 
reproductive medicine. In addition, these innovations have changed the nature of 
agriculture and agricultural economics, as artificial insemination has often supplanted 
natural breeding in intensive production regimens. Research on mature sperm is limited in 
that there are no cell culture systems that support spermatogenesis in vitro; therefore, sperm 
can only be obtained as primary cells from reproductively mature individuals. The stem 
cells that will produce sperm, on the other hand, are present in early neonates. Soon after 
birth in most species, gonocytes migrate to the basement membrane of the seminiferous 
cords; at this point in time the gonocytes transition into spermatogonia.  
The development of reproductive technologies based on SSCs could preserve the breeding 
potential of males that die prior to puberty. This can be of great importance when the 
genetic contribution of a single individual could have significant impact on a long-term 
viability of a population. Examples of this would include attempts to preserve the genetic 
information represented in offspring of founder individuals in captive breeding programs, 
or attempts to propagate individuals with diseases that preclude natural mating. In 
addition, because SSCs can be maintained in culture, these cells are similar to ESCs in 
providing an opportunity for genetic manipulation that is not present in the terminally-
differentiated spermatozoa. Efforts to take advantage of the attributes of SSCs have thus far 
focused on two technologies: spermatogonial stem cell transplantation (SSCT) and testis 
xenografting. 
5. Conclusions 
SSCs are the novel source of pluripotent stem cells that have an advantage over the iPS cells 
in numerous ways. Firstly, pluripotent cells from SSCs do not require the addition of any 
foreign genes as they are spontaneously generated in culture. Secondly, since pluripotent 
cells from SSCs are derived without viral transduction, they provide a safer alternative to 
iPS cells. Finally, SSCs and SSC-derived pluripotent cells can find immediate application in 
the field of regenerative medicine, fertility restoration, and genetic modification of mice and 
large animals and in the conservation of endangered species.  
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